BioSpace News Archive

TransCode Therapeutics, Inc., an RNA oncology company created on the belief that cancer can be defeated through the intelligent design and effective delivery of RNA therapeutics, reported recent business progress and third quarter 2021 financial results.

Aytu BioPharma, Inc., a specialty pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products, reported financial results for its fiscal first quarter 2022 ended September 30, 2021.

Timber Pharmaceuticals, Inc. (“Timber” or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today provided a business update and announced financial results for the third quarter ended September 30, 2021.

Assure Holdings Corp., a provider of intraoperative neuromonitoring services, reported financial results for the third quarter ended September 30, 2021.

ENDRA Life Sciences Inc., a pioneer of Thermo Acoustic Enhanced UltraSound, reported financial results for the three months ended September 30, 2021 and provided a business update.

Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today reported financial results for the third quarter ended September 30, 2021 and provided a corporate update.

Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), today reported its financial results for the third quarter of 2021, and provided a business update.

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced its virtual participation in the following conferences.

The V Foundation for Cancer Research, a top-rated cancer research charity, has awarded grants worth more than $21 million for cutting-edge cancer research in 2021.

Elite Pharmaceuticals, Inc., a specialty pharmaceutical company developing niche generic products, announced results for the second quarter of fiscal year 2022 ended September 30, 2021.